drug

natamycin

1 story · latest Aug 10, 2026

Status: FDA approved Oct 1978 · NDA050514
Brand: Natacyn

Relationships

Developed by Harrow Inc

Timeline

Harrow reports Q2 2026 results, reiterates full-year guidance, cites pipeline progress

Aug 10Quarterly updateHarrow Inc

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.